Antibiotic resistant bacteria are on the rise and winning the battle against available treatments. Our mission is to fight them back.  Our laboratory uses genomics tools to understand the molecular mechanisms controlling bacterial growth with the goal to find novel antibacterial therapies. Our research projects include 1) metabolic inhibition of quorum sensing-related pathogenicity, and 2) chemogenomic approaches to understand the mechanism of action of novel antibacterial molecules. Our current focus is the group of bacteria called “Burkholderia cepacia complex”.